Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.

A total of 101 patients with proven Staphylococcus aureus infection were included in a double-blind, placebo-controlled study; this study compared oxacillin (12 g/day, intravenously) or vancomycin (2 g/day, intravenously) plus rifampin (1,200 mg/day, orally) with oxacillin or vancomycin plus placebo...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Van der Auwera, P, Klastersky, J, Thys, J P, Meunier-Carpentier, F, Legrand, J C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180285/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3907494/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.4.467
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!